WANG Jianxin 1,2,3 , SUN Rui 4,5 , GAO Xuemin 4 , ZHANG Xiafei 6,7 , WEI Bing 6,7 , SUN Yuanyuan 6,7 , GAO Rui 1,2
  • 1. Xiyuan Hospital Affiliated to China Academy of Chinese Medical Sciences, Beijing 100091, P. R. China;
  • 2. NMPA for Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, Beijing 100091, P. R. China;
  • 3. Center for Post-Doctoral Studies, China Academy of Chinese Medical Sciences, Beijing 100091, P. R. China;
  • 4. Beijing University of Traditional Chinese Medicine, Beijing 100105, P. R. China;
  • 5. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 101121, P. R. China;
  • 6. Standardization Project Team of Clinical Application Guidelines of the Chinese Medicines for the Treatment of Common Diseases, Beijing 100061, P. R. China;
  • 7. China Association of Traditional Chinese Medicine, Beijing 100061, P. R. China;
GAO Rui, Email: ruigao@126.com
Chinese patent medicine; Guideline; Implementation evaluation
10.7507/1672-2531.202212108
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective To analyse the quality of implementation in clinical application guidelines of the Chinese patent medicines for the treatment of common diseases. Methods We retrieved clinical application guidelines of the Chinese patent medicines for the treatment of common diseases published from February, 2019 to August, 2022 in databases. The clinical practice guideline (CPG) implementation evaluation tool was used to evaluate the implementation of the included guidelines. Results A total of 29 guidelines were included. The implementation quality of included guidelines was moderate. Thirteen (44.8%) were high quality and 16 (55.2%) were moderate quality. Conclusion The quality of implementation of clinical application guidelines of the Chinese patent medicines for the treatment of common diseases is higher than that of other traditional Chinese medicine CPG. The CPG implementation evaluation tool can be used in traditional Chinese medicine CPGs and particularity of TCM should also be considered.

Citation： WANG Jianxin, SUN Rui, GAO Xuemin, ZHANG Xiafei, WEI Bing, SUN Yuanyuan, GAO Rui. Evaluation of implementation on clinical application guidelines of the Chinese patent medicines for the treatment of common diseases. Chinese Journal of Evidence-Based Medicine, 2023, 23(4): 444-449. doi: 10.7507/1672-2531.202212108 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved